MedTrace Logo

Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel

NCT01637077 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2018-04-06

Study results available
· View outcomes & findings →

Summary

This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.

Conditions

Interventions

DRUG

pregabalin

Given PO

DRUG

placebo

Given PO

OTHER

questionnaire administration

Ancillary studies

Sponsors & Collaborators

  • Academic and Community Cancer Research United

    lead OTHER

Principal Investigators

  • Charles Loprinzi · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-11-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01637077 on ClinicalTrials.gov